Friday, June 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Chemicals

BASF Completes Initial Buyback Phase as €12 Billion Capital Return Program Gathers Pace

Rodolfo Hanigan by Rodolfo Hanigan
June 19, 2026
in Chemicals, DAX, Dividends
0
BASF Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

The first chapter of BASF’s ambitious shareholder payout story is closing. By the end of June, the chemicals giant will have wrapped up the initial €1.5 billion tranche of its share repurchase programme, buying back nearly 31 million shares since last November. Those shares are now being cancelled, reducing the company’s share capital and giving a mechanical boost to the value of every remaining share. But this is only the appetiser: management has pledged to return a total of €12 billion to investors through a combination of buybacks and dividends by the end of 2028.

Under that plan, shareholders can count on an annual dividend of at least €2.25 per share. Combined with the multiple buyback tranches still to come, the payout profile is designed to keep investors rewarded even as the broader chemical industry struggles. The precise schedule for the next buyback phase has yet to be announced, however, leaving the market without a clear near-term demand catalyst once the current programme ends.

On the cost side, BASF is leaning hard on savings to protect its margins. By March the group had already slashed €1.9 billion in costs, and it is targeting a further €2.3 billion in reductions by year-end. That internal discipline paid off in the first quarter, when earnings per share climbed to €1.06. For the full year, BASF expects operating profit before special items to land between €6.2 billion and €7.0 billion, with free cash flow reaching as much as €2.3 billion.

The need for such self-help is acute. Germany’s chemical industry association VCI forecasts that domestic chemical production will shrink in 2026, with falling prices dragging down sector revenues. BASF cannot rely on a tailwind from the broader market; it must generate growth from its own restructuring and cost-cutting initiatives.

Should investors sell immediately? Or is it worth buying BASF?

Meanwhile, the buyback programme itself is winding down with a final push. In mid-June alone, BASF scooped up 235,000 of its own shares on the Xetra electronic trading platform. In total, it has spent the full €1.5 billion allocated to this first tranche, repurchasing roughly 31 million shares. The cancellation of those shares will permanently remove that supply from the market, though the removal of the ongoing buyback support also means the stock loses a structural demand buffer.

At the bourse, BASF shares have held up reasonably well. They currently trade at just under €49, having gained about 9% to 10% since the start of the year. The price sits comfortably above the 200-day moving average, a technical signal that investors have bought into the narrative of operational stability and generous capital returns.

The next major catalyst comes in July 2026, when BASF will report its half-year results. Alongside the quarterly figures, the market will be looking for concrete details on the timing and size of the next buyback tranche. Without that clarity, the recent share price momentum could prove hard to sustain in the face of persistent industry headwinds.

Ad

BASF Stock: Buy or Sell?! New BASF Analysis from June 19 delivers the answer:

The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 19.

BASF: Buy or sell? Read more here...

Tags: BASF
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Bayer Stock
Analysis

Bayer’s All-or-Nothing Summer: A Supreme Court Ruling and a $7.25bn Settlement Duel

June 19, 2026
Deutsche Telekom Stock
DAX

Deutsche Telekom’s Labour Deal Set to Remove Key Uncertainty as Stock Tests Lows

June 19, 2026
Partners Group Stock
Analysis

Partners Group Races to Shore Up Confidence as Retail Redemption Storm Sinks Shares

June 18, 2026
Next Post
Microsoft Stock

Microsoft’s Capacity Crunch and Cash Flow Squeeze Test the AI Thesis

BayWa Stock

BayWa's Revenue Plunges 34% as Legal Probes Mount and Creditors Circle Ahead of Autumn Deadline

Oracle Stock

Inside Oracle's Cash-Burning Engine: Record Demand, a $3 Billion Deal That Got Away, and a $40 Billion Capital Plea

Recommended

Tyler Stock

Institutional Investors Recalibrate Stakes in Government Software Provider

5 months ago
Trinet Stock

Trinet Stock: A Study in Contradictions Amid Steep Decline

10 months ago
Strategy Stock

Conflicting Signals Leave Strategy Investors at a Crossroads

9 months ago
Vulcan Energy Stock

Vulcan Energy Powers Europe’s Lithium Independence Drive

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

Cerebras Races Into First Earnings Report After Back-to-Back Double-Digit Gains

Outlook Therapeutics’ July 16 Shareholder Vote to Decide Nasdaq Fate as FDA Decision Looms on July 29

XPeng’s X9 Dominates Norwegian Range Test, but European Launch Fails to Ignite Stock

ServiceNow’s Q1 Revenue Jumps 22% as AI Bet Pays Off, but Armis Price Tag Weighs on Margins

Trending

Rocket Lab USA Stock
Industrial

Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis

by Rodolfo Hanigan
June 19, 2026
0

Monday will bring Rocket Lab a structural shift that no single launch can match. The stock joins...

Vital Farms Stock

Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight

June 19, 2026
Core Lithium Stock

Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

June 19, 2026
Kuros Biosciences Stock

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

June 19, 2026
Medtronic Stock

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

June 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis
  • Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight
  • Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com